Martin I. Cole, Group Chief Exec-Comm, Med & Tec at Accenture plc (ACN), sold 34,000 shares at $65.24 ($2.2M) on 2012-03-27, disclosed to the SEC on 2012-03-28.
Scheduled sale ($2.2M) by Group Chief Exec-Comm, Med & Tec under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| WDC | SELL | 2026-06-11 | $1.7M | — | Filing → |
| WDC | SELL | 2026-06-11 | $386K | — | Filing → |
| WDC | SELL | 2026-03-03 | $3.1M | — | Filing → |